Esperion Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Esperion Therapeutics, Inc.‘s stocks are currently a part of 135 hedge funds’ portfolios, which represents 95.19% of the total amount of its stocks outstanding. This makes up a total of 60.18M shares of Esperion Therapeutics, Inc.. Compared to the previous quarter, the number grew by 8.78% or 4.85M shares more. As for the holding position changes, 38.52% (52) of current hedge fund investors increased the number of shares held, 28.89% (39) of current holders sold a part of the shares held, and 6.67% (9) closed the holdings completely. 20 hedge funds are new holders of Esperion Therapeutics, Inc. stock in Q3 2022, it is 14.81% of total holders.
Hedge funds holding Esperion Therapeutics (Q4 2017 – Q3 2022)
| Q4 2017 | 164 |
|---|---|
| Q1 2018 | 185 |
| Q2 2018 | 152 |
| Q3 2018 | 151 |
| Q4 2018 | 150 |
| Q1 2019 | 157 |
| Q2 2019 | 163 |
| Q3 2019 | 144 |
| Q4 2019 | 168 |
| Q1 2020 | 161 |
| Q2 2020 | 177 |
| Q3 2020 | 160 |
| Q4 2020 | 151 |
| Q1 2021 | 150 |
| Q2 2021 | 136 |
| Q3 2021 | 136 |
| Q4 2021 | 126 |
| Q1 2022 | 124 |
| Q2 2022 | 134 |
| Q3 2022 | 135 |
Hedge funds changes in Esperion Therapeutics positions (Q4 2017 – Q3 2022)
| Q4 2017 | 43 | 49 | 51 | 28 | -7 |
|---|---|---|---|---|---|
| Q1 2018 | 39 | 69 | 54 | 17 | 6 |
| Q2 2018 | 20 | 67 | 43 | 52 | -30 |
| Q3 2018 | 24 | 50 | 47 | 25 | 5 |
| Q4 2018 | 24 | 51 | 51 | 25 | -1 |
| Q1 2019 | 27 | 57 | 40 | 20 | 13 |
| Q2 2019 | 33 | 60 | 38 | 23 | 9 |
| Q3 2019 | 12 | 48 | 49 | 31 | 4 |
| Q4 2019 | 46 | 54 | 41 | 15 | 12 |
| Q1 2020 | 32 | 54 | 49 | 37 | -11 |
| Q2 2020 | 40 | 65 | 40 | 24 | 8 |
| Q3 2020 | 14 | 50 | 60 | 27 | 9 |
| Q4 2020 | 17 | 50 | 50 | 26 | 8 |
| Q1 2021 | 20 | 43 | 53 | 22 | 12 |
| Q2 2021 | 17 | 42 | 45 | 31 | 1 |
| Q3 2021 | 25 | 33 | 38 | 24 | 16 |
| Q4 2021 | 43 | 43 | 24 | 53 | -37 |
| Q1 2022 | 31 | 39 | 29 | 31 | -6 |
| Q2 2022 | 26 | 41 | 42 | 15 | 10 |
| Q3 2022 | 20 | 52 | 39 | 9 | 15 |
Hedge funds changes in Esperion Therapeutics stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 32,937,000 | 34,665,000 |
|---|---|---|
| Q1 2018 | 75,409,000 | 79,440,000 |
| Q2 2018 | 16,420,000 | 50,812,000 |
| Q3 2018 | 31,310,000 | 59,589,000 |
| Q4 2018 | 28,857,000 | 20,613,000 |
| Q1 2019 | 12,952,000 | 22,625,000 |
| Q2 2019 | 22,651,000 | 20,817,000 |
| Q3 2019 | 16,114,000 | 16,477,000 |
| Q4 2019 | 36,302,000 | 27,715,000 |
| Q1 2020 | 7,945,000 | 12,232,000 |
| Q2 2020 | 38,097,174 | 24,935,327 |
| Q3 2020 | 23,290,000 | 15,472,000 |
| Q4 2020 | 9,367,000 | 14,328,000 |
| Q1 2021 | 5,512,000 | 17,847,000 |
| Q2 2021 | 7,578,000 | 17,700,000 |
| Q3 2021 | 6,250,000 | 11,001,000 |
| Q4 2021 | 2,275,000 | 3,042,000 |
| Q1 2022 | 3,535,000 | 1,019,000 |
| Q2 2022 | 6,445,000 | 1,619,000 |
| Q3 2022 | 14,288,000 | 3,171,000 |